Effect of Anti-malaria Drugs on Some Blood Cell Lines Parameters in Adult Individuals Infected with Acute Uncomplicated Plasmodium falciparum Malaria

ESAN AYODELE. J^1,

¹Department of Haematology and Blood Transfusion Science, Federal Medical Centre, Ido-Ekiti Ekiti State

Cite this paper:
ESAN AYODELE. J. Effect of Anti-malaria Drugs on Some Blood Cell Lines Parameters in Adult Individuals Infected with Acute Uncomplicated Plasmodium falciparum Malaria. International Journal of Hematological Disorders. 2014; 1(1):12-21. doi: 10.12691/ijhd-1-1-3

Abstract

Malaria remains a major public health problem in Nigeria where it is endemic, especially in rural populations as is the case elsewhere in Africa, it causes significant human suffering and impacts on social and economic development. The aim of this study is to determine the prevalence and severity of malaria parasitaemia in adult individuals caused by P. falciparum and to determine the effects of anti-malaria drugs on some blood cell line parameters. 202 confirmed malaria infected patients were recruited for the study between the ages of 15 – 64 years of both sexes at the general outpatient clinic of the Federal Medical Centre, Ido-Ekiti, Nigeria. 4ml of blood sample was collected twice from the same patient before and after taking anti-malaria drug for blood cell lines analysis. Malaria parasite detection, malaria parasite count and malaria parasite species identification were determined. All the subjects were infected with Plasmodium falciparum specie; 129(63.9%) were males and 73(36.1%) were females. In pre anti-malaria drug treatment group, mean ± SD of relative and absolute neutrophil 60.18 ± 9.41 and 4.16 ± 1.69 respectively in age group A were higher compared to other age groups, the difference was statistically significant (p<0.05) except in relative neutrophil. Changes in the white blood cell lines are less dramatic in adult individuals infected with acute uncomplicated malaria; proper malaria control strategies targeted at the less immune age group especially young adult and aging will likely reduce the burden of malaria resulting in greater clinical and haematological benefits.

Keywords:
anti-malaria drug blood cell lines malaria parasite

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Greenwood B. Malaria mortality and morbidity in Africa. Bulletin of the World Health Organization, (1999); 77(8): 617-618.
[2]	World Health Organization. World Malarial Report 2011. Fact Sheet. Available at www.who.int/malaria/world_malaria. (2011)./WMR2011_factsheet.pdf.
[3]	Klinkenberg E, McCall PJ, Hastings IM, Lengeler C, Bates I, D’Alessandro U, Barnish G, Klinbenberg E, Townson H, Trape JF. Malaria and irrigated crops, Accra, Ghana. Emerg. Inf. Dis. (2005); 11(8): 1290-1293.
[4]	World Health Organization. World Malaria Report. WHO, Switzerland. (2008) pp. 99-101.
[5]	National Bureau of Statistics. National Census. (2006) http//www.nigerianstat.gov.ng/Connection/Pop2006.pdf.
[6]	Roll Back Malaria RBM. Facts about malaria in Nigeria, Abuja. Publication of the Roll Back Malaria. (2005) Pp.1-2.
[7]	Federal Ministry of Health. Malaria Desk Situation Analysis Federal Ministry of Health. Publication of the FMH, Nigeria, FGN Publication. (2005b) P 27.
[8]	Hommel, M. Steps towards a malaria vaccine. Res. Immunol., (1991); 142: 618-631.
[9]	Akanbi, O.M., A.B. Odaibo and O.G. Ademowo. Effect of age and anti- MSP1 (19) antibody (IgG) level on prevalence of malaria in pregnancy in south-western Nigeria. Sci. Res. Ann., (2006)2: 33-38.
[10]	Bereczky S, Liljander A, Rooth I. Multiclonal asymptomatic plasmodium falciparum infections predict a reduced risk of malaria disease in a Tanzanian population. Microbes Infect; (2007); 9: 103-110.
[11]	Despommier D. D, Gwadz R. W, Hotez P.J, Knirsch C.A. Parasitic diseases. 5th ed. New York, NY (2005): Apple Tree Productions.
[12]	Dubey ML, Weingken C, Ganguly NK, Mahajan RC. Comparative evaluation of methods of malaria parasite density determination in blood samples from patients and experimental animals. Indian J Med Res; (1999); 109: 20-27.
[13]	Haynes RK. Artemisinin and derivatives: The future for malaria treatment? Curr Opin Infect Dis (2001); 14: 719-726.
[14]	World Health Organization (WHO). Guidelines for the Treatment of Malaria. Geneva: (2006); World Health Organization.
[15]	White NJ. “Antimalarial drug resistance”. J. Clin. Invest. (2004); 113 (8): 1084-1092.
[16]	Krishna. S. “Artemisinins: mechanisms of action and potential for resistance”. Drug Resistance Updates (2004); 7: 233-244.
[17]	Maina RN, Walsh D, Gaddy C, Hongo G, Waitumbi J, Otieno L, Jones D, Ogutu BR Impact of Plasmodium falciparum infection on haematological parameters in children living in Western Kenya. Malar. J. (2010); 9(3):S4.
[18]	Ladhani S, Lowe B, Cole AO, Kowuondo K, Newton CR. Changes in white blood cells and platelets in children with falciparum malaria: Relationship to disease outcome. Br. J. Haematol. (2002); 119: 839 847.
[19]	Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen, ter Kuile F, Chongsuphajaisiddhi T, White NJ. Factors contributing to anaemia after uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. (2001); 65: 614-622.
[20]	Monica Cheesbrough. Discrete Laboratory Practice in Tropical Countries Part 1, Cambridge Second Editions. Published by Press Syndicate of the University of Cambridge, (2005); chp. 5, page 247-258.
[21]	Dayachi F, Kabongo L, Ngoie K. Decreased mortality from Malaria in children with symptomatic HIV infection. Int. Cont. (1991); AIDS 2: 164.
[22]	Warhurst, D.C. and J.E. Williams. Acp Broadsheet no 148. July 1996. Laboratory diagnosis of malaria. J. Clin. Pathol, (1996) 49: 533-538.
[23]	Franks S, Koram K.A, Wagner G.E. Frequent and persistent, asymptomatic plasmodium falciparum infections in African infants, characterized by multilocus genotyping. J Infect Dis; (2001); 183:796-804.
[24]	Bruce M.C, Donnelly C.A, Packer. Age and species-specific duration of infection in asymptomatic malaria infections in Papua New Guinea. Parasitology; (2000); 121: 247-256.
[25]	Quakyi I.A, Leke R.G, Befidi-Mengue R. The epidemiology of plasmodium falciparum malaria in two Cameroonian villages; Simbok and Etoa. AmJ Trop Med Hyg; (2000); 63: 222-230.
[26]	McKenzie FE, Prudhomme WA, Magill AJ, Forney JR, Permpanich B, Lucas C, Gasser Jr RA and Wongsrichanalai C. White blood cell counts and malaria. J. Infect. Dis., (2005); 192: 323-330.
[27]	Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WR. Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet; (2002); 359:1365-72.
[28]	Taha K, El-Dein Z, Idrees M, Makboul G, Ghassan B. Hematological changes in malaria: relation to plasmodium species. Kuwait Med J., (2007); 39 (3): 262-267.
[29]	Sumbele Irene Ule Ngole, Nkuo-Akenji Theresa, Samje Moses, Ndzeize Thomas Ngwa Elsy Manka and Titanji V. P. K. Haematological changes and recovery associated with treated and untreated Plasmodium falciparum infection in children in the Mount Cameroon Region Journal of Clinical Medicine and Research. (2010); 2(9), 143-151.
[30]	Facer CA. Hematological aspects of malaria. Infection and Haematology. Oxford: Butterworth Heinmann Ltd. (1994): 259-294.
[31]	Abdalla SH. Peripheral blood and bone marrow leucocytes in Gambian children With malaria: numerical changes and evaluation of phagocytosis. Ann Trop Paediatr; (1998); 8: 250-258.
[32]	Amodu OK, Adeyemo AA, Olumese PE, Gbadegesin RA. Intraleucocytic malaria pigment and clinical severity of malaria in children. Trans R Soc Trop Med Hyg; (1998); 92: 54-56.
[33]	Molyneux, M. E., Hien, T. T. and White, N. Clinical Features and Prognostic Indicators in Paediatic Cerebral Malaria: A Study of 131 Comatose Malawian Children. Q. J. Medicine (1989); 78:441.
[34]	Lathia TB, Joshi R. Can hematological parameters discriminate malaria from non malarious acute febrile illness in the tropics? Indian J Med Sci. (2004); 58 (6): 239-244.
[35]	Bhushan Katira & Ira Shah. Thrombocytopenia in Plasmodium vivax infected children. J Vect Borne Dis (2006); 43, pp. 147-149.
[36]	Abdalla S, Pasvol G. Platelets and blood coagulation in human malaria. In: Newton PN, Essien E, White NJ, editors. The Haematology of Malaria. London, UK: Imperial College Press: (2004); 249-276.
[37]	Tan SO, McGready R, Zwang J, et al. Thrombocytopenia in pregnant women with malaria on the Thai-Burmese border. Malaria J; (2008); 7: 209.
[38]	Rogerson SJ, Hvid L, Duffy PE, Leke RFG, Taylor DW. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis. (2007); 7: 105-117.